The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, however its future within the broader sector now raises questions about potential yields . Generic versions are eroding market share, causing worries that investing in companies heavily reliant to Viagra's former influence could be a problematic strategy, especi